| |
|
|
|
|
|
|
|||
|
Blood, 15 September 2006, Vol. 108, No. 6, pp. 2124-2126. Prepublished online as a Blood First Edition Paper on May 25, 2006; DOI 10.1182/blood-2006-03-009712.
TRANSPLANTATION Serial transplantation of mismatched donor hematopoietic cells between HLA-identical sibling pairs with congenital immunodeficiency: in vivo tolerance permits rapid immune reconstitution following T-replete transplantation without GVHD in the secondary recipientFrom the Departments of Bone Marrow Transplantation and Clinical Immunology, Great Ormond Street Hospital National Health Service (NHS) Trust, London, United Kingdom; the Molecular Immunology Unit, Institute of Child Health, University College London, London, United Kingdom; the Clinical Transplantation Laboratory, Barts and The London NHS Trust, London, United Kingdom; and the Department of Haematology and Bone Marrow Transplantation, Manchester Royal Infirmary, Manchester, United Kingdom.
We report serial transplantation procedures in 2 sets of brothers with X-linked primary immunodeficiency. The first boy in each family received a T-celldepleted transplant from a mismatched donor. The recipients then acted as donors for T-replete transplantation of the "tolerized" graft into their HLA-identical brothers with the same disorder. Immune reconstitution was noted to occur at a significantly faster rate in the secondary recipients, and without the occurrence of graft-versus-host disease (GVHD), despite the presence of donor cells mismatched for 1 to 3 HLA antigens. This serial transplantation technique allows the primary recipient of HLA-mismatched donor cells to act as a functionally "HLA-matched" donor for subsequent affected siblings, and should be considered as a therapeutic option in families with congenital disorders.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||